Dumfries & Galloway Health Board
Prescribing Support Team

Calcium Channel Blockers

Posted: 24 Jun 14 Edited: 13 Aug 18
Audits Cardiovascular

This audit aims to ensure that the budget invested in the NHS D&G Joint Formulary calcium channel blockers (CCBs) for the management of hypertension and angina is cost effective and rational.

Amlodipine is the most cost effective CCB in its class and the review will facilitate identification of patients for whom this would be an appropriate CCB. Formulary compliance will also be reviewed with this audit.